Literature DB >> 717941

Intravenous antibiotic therapy at home.

H G Stiver, G O Telford, J M Mossey, D D Cote, E J van Middlesworth, S K Trosky, N L McKay, W L Mossey.   

Abstract

During a 12-month period, 23 patients aged 12 to 78 years were treated for 8 to 40 days (mean, 23 days) at home with intravenous (i.v.) antibiotics. Diseases treated included bone and joint infection (14 patients), blastomycosis (two), actinomycosis (two), staphylococcal bacteremia (two), endocarditis (two), and candidal pyelonephritis (one). After initial in-hospital training, patients self-administered their drugs through a heparin-lock i.v. cannula, which was changed regularly by a visiting home care nurse. Antibiotics administered included cloxacillin, penicillin G, cephalosporins, gentamicin, carbenicillin, and amphotericin B. Patient and family acceptance of the program was good, the program was therapeutically effective, and, apart from a decreased prevalence of phlebitis with the heparin lock at home, side effects were no different from those of in-hospital-treated patients. The cost of home therapy was $ 40 per patient-day compared with an estimated $ 137 had the patients remained in hospital. Most patients were able to resume normal activities while receiving home i.v. therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 717941     DOI: 10.7326/0003-4819-89-5-690

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

Review 1.  Economics of home intravenous services.

Authors:  N D Thickson
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

2.  Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.

Authors:  D N Williams; J L Raymond
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

3.  Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks?

Authors:  D N Williams
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

4.  Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.

Authors:  A O Wai; L Frighetto; C A Marra; E Chan; P J Jewesson
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

5.  Outpatient parenteral antimicrobial therapy.

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

6.  Home iv antibiotic therapy through a medical day care unit.

Authors:  M Gourdeau; L Deschênes; M Caron; M Desmarais
Journal:  Can J Infect Dis       Date:  1993-05

Review 7.  The health and cost effects of substituting home care for inpatient acute care: a review of the evidence.

Authors:  L Soderstrom; P Tousignant; T Kaufman
Journal:  CMAJ       Date:  1999-04-20       Impact factor: 8.262

Review 8.  Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.

Authors:  Richard S Slavik; Peter J Jewesson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Self-administration of intravenous antibiotics: an efficient, cost-effective home care program.

Authors:  H G Stiver; S K Trosky; D D Cote; J L Oruck
Journal:  Can Med Assoc J       Date:  1982-08-01       Impact factor: 8.262

10.  Willingness to pay to assess patient preferences for therapy in a Canadian setting.

Authors:  Carlo A Marra; Luciana Frighetto; Alan F Goodfellow; Amy O Wai; M Lynn Chase; Ruth E Nicol; Carole A Leong; Sally Tomlinson; Barbara M Ferreira; Peter J Jewesson
Journal:  BMC Health Serv Res       Date:  2005-06-07       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.